IL33 and Atrophy: Most importantly, we found that IL-33 could alleviate disuse muscle atrophy in aged mice, suggesting a potential therapeutic application of this signaling pathway for the treatment of disuse muscle atrophy in the elderly, a condition for which no established medical intervention currently exists.